The three approved sites
Abdomen (avoiding two inches around the navel), the front of the thigh, or the back of the upper arm. All work equally well; the rule that matters is rotation – a different spot each week keeps skin healthy.
The unhurried routine
Take the pen from the fridge and let it sit a few minutes. Wash hands, clean the site, unlock the pen, press it flat against skin, and push the button: a first click starts the dose, and the injection is done when you hear the second click and see the gray plunger. Count to ten before lifting.
What is normal after
A small drop of blood or brief sting at the site is common; a pea-sized bump that fades within a day or two can happen. Redness that spreads, welts, or pain that grows deserve a clinician message.
Approval status for every brand product is verifiable in Drugs@FDA.
The habits that make it easy
Same day each week, an alarm on your phone, and pens stored in the fridge door where you see them. If a dose is missed, follow your dispensed instructions for timing – never inject two to catch up. See the 30-second film answers for this medication.
Administering it correctly, in plain terms
Follow the instructions your dispensing pharmacy provides with your specific preparation, because concentration differs between products and that is what determines the volume you draw. Most weekly peptide injections are subcutaneous, into fat rather than muscle, using the abdomen away from the navel, the outer thigh, or the back of the upper arm. Rotating the site each week reduces local irritation. Supplies arrive with the shipment: syringes, alcohol swabs, and a sharps container. Units and milligrams are not interchangeable, and confusing them is the most common self-administration error, which is why units versus milligrams exists as its own article. If anything about your dose, volume, or schedule is unclear, contact the pharmacy or your clinician before injecting rather than estimating.
How tirzepatide works on two receptors at once
Tirzepatide is a single molecule that activates two incretin receptors: GIP and GLP-1. Both are receptors your gut already uses. After a meal, the intestine releases incretin hormones that tell the pancreas to release insulin, slow how fast the stomach empties, and signal fullness to the hypothalamus. Tirzepatide binds those same receptors, so the signal is present at a steadier level than it would be from food alone. The GLP-1 arm is the one most people have heard of. The GIP arm is what distinguishes tirzepatide from semaglutide, which acts on GLP-1 only. According to the FDA prescribing information for tirzepatide products, dual agonism is the mechanism of record. What that difference means for any individual is a clinical question, not a settled one, and a licensed clinician decides whether the medication is appropriate for you at all.
What compounded means, and what it does not
A compounded preparation is made by a licensed pharmacy for an individual patient on receipt of a valid prescription. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before they are marketed. That is a statement about regulatory pathway, not an accusation about any particular pharmacy, and it is why the distinction matters more than marketing language does. A compounded preparation is not a generic and not an equivalent of any FDA-approved brand product. Published clinical trials such as SURMOUNT-1 studied the branded product at studied doses; those findings should not be assumed to transfer. What compounded means unpacks the legal framework, and red flags when buying online covers how to tell a legitimate pharmacy from a grey-market seller.
Why side effects are mostly digestive, and mostly early
Because the receptors tirzepatide acts on sit in the gut and the brainstem, the predictable effects are digestive: nausea, reflux, constipation, diarrhoea, and a feeling of fullness that arrives sooner than expected. According to FDA prescribing information for tirzepatide products, gastrointestinal reactions are the most commonly reported adverse events, and they are dose-related for many people. The practical implication is that they tend to cluster around a dose change rather than persist indefinitely. Serious risks are listed separately in the label, including pancreatitis, gallbladder disease, and a boxed warning for thyroid C-cell tumours in rodents. Those are not common, but they are the reason the medication is prescription-only. Report severe or persistent abdominal pain, vomiting that stops you keeping fluids down, or vision changes to your clinician promptly rather than waiting for a scheduled check-in.
Answer a few questions. A licensed clinician decides what, if anything, is appropriate.
Frequently asked questions
Does it hurt?
The needle is thin and hidden; most people describe a brief pinch. Cold pens sting more – room temperature helps.
Can someone else inject for me?
Yes – the back-of-arm site in particular is easier with help.
What do I do with used pens?
Into an FDA-cleared sharps container or a heavy plastic container with a screw lid – never loose household trash.
Is compounded tirzepatide the same as Zepbound?
No. Zepbound is an FDA-approved product; a compounded preparation is made by a licensed pharmacy for an individual patient and is not FDA-approved. FDA does not review compounded preparations for safety, effectiveness, or quality before marketing, and a compounded preparation is not a generic or an equivalent.
What is the starting dose of compounded tirzepatide?
Your prescribing clinician sets the starting dose and the titration schedule, and the dispensing pharmacy supplies instructions for your specific concentration. There is no single published starting dose for compounded preparations, and units and milligrams are not interchangeable.
How long can compounded tirzepatide be out of the fridge?
Follow the storage instructions supplied with your preparation, because the permitted excursion window depends on the exact formulation. If a package arrives warm, leaking, cloudy, or damaged, contact the dispensing pharmacy rather than using it.
Prefer a walkthrough with a human?
A licensed clinician reviews your history and your care team stays available by message. Rx only, refunded in full if you are not prescribed.
Rx only. A licensed clinician decides whether treatment is appropriate and may determine that no treatment, or a different treatment, is right for you. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Individual results vary.
Sources
Clinical trials listed below evaluated FDA-approved products at the doses studied. They are cited as published science, not as evidence about any compounded preparation, which is not FDA-approved and has not been evaluated by FDA for safety, effectiveness, or quality.
- FDAFDA prescribing information and instructions for use: Zepbound
- FDAFDA. Safely using sharps at home
- FDA databaseDrugs@FDA: search approved labeling for tirzepatide
- Peer-reviewedSURMOUNT-1: Tirzepatide Once Weekly for the Treatment of Obesity (NEJM 2022)
Spotted something inaccurate? Report an error – corrections are logged per our editorial standards.
More on Brand-Name Pens
Same medication, different question.
